Should I take low‑dose aspirin in pregnancy? Use calculator

Quick take: Low‑dose aspirin (usually 81 mg daily) is safe for most pregnant people when prescribed, and it can lower the risk of pre‑eclampsia and other complications in high‑risk pregnancies. It’s not a routine supplement for every pregnancy—your provider will decide based on your medical history, timing, and any other medicines you’re taking.

It’s 2 a.m., you’ve just read another article about “miracle” supplements, and a lingering question keeps tugging at you: “Should I take low‑dose aspirin in pregnancy?” You’re not alone. Many expecting parents wonder whether a tiny tablet can protect against serious conditions like pre‑eclampsia, or whether it might pose hidden dangers to the baby.

Below you’ll find a clear, evidence‑based walk‑through: what low‑dose aspirin is, why some clinicians recommend it, who benefits most, how to use it safely, and what warning signs should send you straight to your provider. We’ll also give you a quick‑reference table, a handy checklist, and a link to a calculator that lets you see your personal risk profile.

By the end of this guide you’ll know exactly whether low‑dose aspirin belongs in your prenatal plan, and you’ll have concrete questions ready for your next appointment.

What is low‑dose aspirin and how does it work in pregnancy?

Low‑dose aspirin, often called “baby aspirin,” is a single‑strength tablet containing about 81 mg of acetylsalicylic acid. In higher doses aspirin reduces pain and inflammation, but at low doses it mainly blocks a substance called thromboxane A2. Thromboxane A2 makes platelets stick together and narrows blood vessels.

During pregnancy, especially in the placenta, a delicate balance of clot‑forming (thromboxane) and clot‑preventing (prostacyclin) chemicals is crucial. In some high‑risk pregnancies this balance tips toward excess clotting, which can raise blood pressure and reduce blood flow to the uterus. Low‑dose aspirin gently nudges the balance back toward prostacyclin, helping keep the placental vessels open and reducing the chance of pre‑eclampsia, fetal growth restriction, and stillbirth.

Guidelines from the American College of Obstetricians and Gynecologists (ACOG) and the UK’s National Institute for Health and Care Excellence (NICE) both describe this mechanism and endorse low‑dose aspirin for specific risk groups, typically starting before 20 weeks’ gestation.

Pharmacokinetically, the low dose is absorbed quickly from the gut, reaches peak plasma levels within 30‑40 minutes, and has a half‑life of roughly 3‑4 hours. Because the dose is below the threshold that interferes with fetal organ development, the drug’s presence in the fetal circulation is minimal, which is why major teratogenic effects have not been observed in large trials.

Beyond the placenta, low‑dose aspirin’s anti‑platelet effect also modestly improves maternal endothelial function, a factor that contributes to healthier blood pressure control throughout pregnancy. This systemic benefit, though less dramatic than the placental effect, adds another layer of protection for women who already have vascular risk factors.

Benefits of low‑dose aspirin in pregnancy

W

• Reduced risk of pre‑eclampsia: ACOG’s 2020 Committee Opinion reports a 30‑40 % relative risk reduction for women who start 81 mg daily before 16 weeks and continue through 36 weeks.
• Lower chance of fetal growth restriction (FGR): Meta‑analyses of randomized trials show a 20 % decrease in FGR when aspirin is started early.
• Decreased stillbirth rates: The WHO’s 2022 guidance notes a modest but meaningful drop in stillbirth among high‑risk groups taking aspirin.
• Potential benefit for recurrent miscarriage: Some small studies suggest aspirin combined with progesterone may improve live‑birth rates in women with antiphospholipid syndrome.

These benefits are most pronounced when aspirin is begun before 16 weeks and when the pregnant person has at least one major risk factor (e.g., prior pre‑eclampsia, chronic hypertension, kidney disease, diabetes, or a history of multiple miscarriages).

Beyond the immediate pregnancy outcomes, research suggests that women who used low‑dose aspirin during pregnancy may experience a lower long‑term risk of cardiovascular disease, mirroring the protective effect seen in non‑pregnant populations. For the infant, better placental perfusion can translate into healthier birth weights and reduced need for neonatal intensive care, though these downstream effects are still being studied.

Importantly, the benefit‑risk ratio remains favorable even in women with overlapping risk factors, such as obesity combined with chronic hypertension. In such cases, the absolute risk reduction can be as high as 10 percentage points, meaning that for every ten women treated, one case of severe pre‑eclampsia may be prevented.

Risks and side effects of low‑dose aspirin during pregnancy

Even low‑dose aspirin isn’t completely risk‑free. The most common side effects are mild and include stomach upset, heartburn, or mild bruising. More serious, but rare, concerns include:

• Bleeding complications: Aspirin can prolong bleeding time. In the third trimester, excessive bleeding during delivery is a theoretical risk, though studies show the overall increase is small when the dose stays ≤ 150 mg.
• Placental abruption: Very high doses (> 150 mg) have been linked to early placental separation, but low‑dose regimens are not associated with this outcome.
• Allergic reactions: People with a known aspirin or NSAID allergy should avoid it.
• Interaction with other medications: Aspirin can enhance the effects of anticoagulants (e.g., heparin) and certain antihypertensives, so your provider will review all prescriptions.

Overall, the consensus from ACOG, NICE, and the CDC is that low‑dose aspirin’s benefits outweigh its risks for the approved high‑risk groups, provided you follow dosing recommendations.

If you experience persistent stomach pain, black stools, or any sign of gastrointestinal bleeding, contact your provider promptly. Most clinicians will suggest taking the tablet with food or switching to an enteric‑coated formulation to protect the stomach lining, and they may order a brief blood count to ensure platelet levels remain stable.

In rare cases, aspirin can exacerbate pre‑existing ulcer disease. For women with a history of peptic ulcers, the FDA advises using the lowest effective dose and monitoring with a gastro‑enterology specialist if symptoms arise. This precaution helps maintain the balance between protection against pre‑eclampsia and gastrointestinal safety.

Who is a good candidate for low‑dose aspirin therapy in pregnancy?

Guidelines converge on a core list of risk factors that make low‑dose aspirin advisable:

If you have none of these risk factors, most clinicians will not prescribe aspirin routinely. However, if you’re unsure, ask your provider to calculate your personal risk using tools like the Aspirin for Preeclampsia calculator.

Risk calculators incorporate age, body‑mass index, ethnicity, and prior obstetric history to generate an individualized probability. For example, Black and South‑Asian women have a statistically higher baseline risk of pre‑eclampsia, which can shift the threshold for recommending aspirin in some guidelines.

Conversely, you should avoid low‑dose aspirin if you have any of the following:

• Known aspirin allergy or severe NSAID sensitivity
• Active peptic ulcer disease or uncontrolled gastro‑intestinal bleeding
• Bleeding disorders (e.g., hemophilia, severe thrombocytopenia)
• Severe liver disease that impairs clotting factor production

Women with borderline risk factors—such as a BMI ≥ 30 kg/m² combined with a modest hypertension reading—may still be offered aspirin after a shared‑decision discussion. The NHS’s 2021 guidance highlights that “clinical judgment” should weigh the incremental benefit against the small increase in bleeding risk.

How to take low‑dose aspirin safely during pregnancy

When your provider prescribes low‑dose aspirin, follow these practical steps:

1. Timing: Take the tablet in the evening with a small snack. Evening dosing aligns with the body’s natural circadian rhythm of platelet activity, which peaks at night.
2. Consistency: Aim for the same time each day. Missing a few doses occasionally isn’t catastrophic, but regular use maximizes the protective effect.
3. Food safety: A light snack (e.g., a piece of toast or a few crackers) helps protect your stomach lining. If you experience heartburn, consider a buffered aspirin formulation, but only after checking with your provider.
4. Medication review: Bring a complete list of all prescriptions, over‑the‑counter meds, and supplements to each prenatal visit. Common interactions include:
   • Heparin or low‑molecular‑weight heparin (LMWH) – may increase bleeding risk.
   • Non‑steroidal anti‑inflammatory drugs (NSAIDs) – additive effect on stomach irritation.
   • Some antihypertensives (e.g., ACE inhibitors) – rarely combined in pregnancy, but coordination is essential.
5. Monitoring: Your provider will likely check blood pressure, urine protein, and sometimes platelet counts every 4‑6 weeks. Any sudden increase in bleeding (e.g., heavy nosebleeds, gum bleeding, or prolonged spotting) should be reported.

Store the tablets in a cool, dry place away from direct sunlight, and keep them out of reach of children. If you miss a dose, simply take it as soon as you remember—unless it’s close to the next scheduled dose, in which case skip the missed one and resume your regular schedule. Do not double up, as that can increase gastrointestinal irritation.

For women who struggle with stomach upset, an enteric‑coated aspirin (often labeled “EC”) can be a gentler option. The coating delays dissolution until the tablet reaches the small intestine, reducing direct gastric exposure while preserving the anti‑platelet effect.

The role of low‑dose aspirin in preventing pre‑eclampsia and other pregnancy complications

Pre‑eclampsia is a potentially life‑threatening condition marked by high blood pressure and organ dysfunction after 20 weeks. It’s the leading cause of maternal mortality worldwide. Low‑dose aspirin works by:

• Improving placental blood flow, reducing hypoxia‑driven inflammation.
• Modulating the immune response that can trigger endothelial damage.
• Limiting the over‑production of thromboxane, which otherwise narrows vessels.

Large‑scale trials, such as the ASPRE study (published in The Lancet 2019), found a 62 % reduction in early‑onset pre‑eclampsia (< 34 weeks) when aspirin was started at ≤ 16 weeks in high‑risk women. The study used 150 mg daily, but later ACOG guidance affirmed that 81 mg is sufficient for most U.S. patients, with similar relative risk reductions.

Beyond pre‑eclampsia, aspirin may lower the incidence of:

• Pre‑term birth (< 37 weeks) linked to placental insufficiency.
• Intrauterine growth restriction (IUGR) in high‑risk pregnancies.
• Stillbirth related to placental thrombosis.

These benefits are not universal; they hinge on early initiation (ideally before 16 weeks) and adherence throughout the second and early third trimesters. Ongoing research is evaluating whether aspirin can also reduce postpartum hypertension, but current guidance does not yet recommend routine continuation after delivery unless a separate indication exists.

In practice, clinicians often combine aspirin with low‑dose calcium supplementation (1 g daily) for women with low dietary calcium, as NICE recommends. This combination appears synergistic, further lowering pre‑eclampsia rates in some populations.

When to start and stop taking low‑dose aspirin during pregnancy

Start: Most guidelines advise beginning low‑dose aspirin as soon as the risk is identified, but no later than 16 weeks. For antiphospholipid syndrome or women with a history of early pre‑eclampsia, starting as early as 12 weeks is common.

Stop: The usual stopping point is 36 weeks gestation, just before the typical onset of labor, to reduce bleeding risk during delivery. Some clinicians continue until the day of birth if the individual has a very high risk of late‑onset pre‑eclampsia, but they will weigh that decision carefully.

It’s crucial to keep a written plan (often provided on a prenatal card) that lists the start date, dosage, and stop date, so you and any covering caregivers stay coordinated. For patients with chronic hypertension or antiphospholipid syndrome, postpartum continuation of low‑dose aspirin may be advised to protect maternal cardiovascular health, but that decision is made after delivery.

When you approach the planned stop week, your provider may reassess blood pressure trends and fetal growth. If the pregnancy remains uncomplicated, many clinicians simply discontinue aspirin at 36 weeks. If concerns persist, a short extension (up to 38 weeks) can be considered, but only under close supervision.

Practical checklist for low‑dose aspirin use

Use this list at each prenatal visit to confirm you’re on track:

• ✅ Confirm the correct dosage (81 mg) and brand (enteric‑coated if recommended).
• ✅ Verify the start date (≤ 16 weeks) and planned stop date (≈ 36 weeks).
• ✅ Review all other medications for potential interactions.
• ✅ Discuss any new symptoms: unusual bruising, heavy menstrual‑type bleeding, severe stomach pain.
• ✅ Ensure blood pressure is being monitored at least every 4 weeks.
• ✅ Ask for a copy of the Aspirin for Preeclampsia risk calculator to see your individualized benefit.

Document the aspirin plan in your electronic health record and bring a printed copy to any labor‑and‑delivery facility. This helps the obstetric team avoid inadvertent discontinuation and ensures that anesthesia providers are aware of the antiplatelet therapy.

When you travel or visit a different clinic, keep the checklist in a portable format (e.g., a note on your phone). Having the information handy makes it easier for any new provider to continue the regimen safely.

From our medical team: “If you fall into a high‑risk category, low‑dose aspirin is one of the safest, most evidence‑based interventions we have to protect both you and your baby. The key is to start early, stay consistent, and keep your provider in the loop about any new symptoms or medication changes.”

Aspirin and prenatal lab tests

Low‑dose aspirin can mildly affect certain laboratory values, most notably platelet count and bleeding time. While routine prenatal labs rarely include bleeding time, a complete blood count (CBC) performed after 20 weeks may show a marginal reduction in platelet numbers, typically still within the normal range. Your provider will interpret these results in context and may repeat the CBC if a significant drop is noted.

Other labs, such as serum creatinine or liver enzymes, are not directly altered by aspirin at the 81 mg dose. However, if you are also taking other medications that affect kidney function (e.g., certain antihypertensives), the provider may monitor renal markers more closely. Discuss any upcoming lab work with your care team so they can note your aspirin use and avoid unnecessary alarm.

In rare instances, aspirin can modestly elevate the prothrombin time (PT) if combined with other antiplatelet agents. While this is usually not clinically relevant at low doses, it’s worth mentioning during a pre‑operative assessment (e.g., for a planned cesarean) so the anesthesiology team can plan appropriate timing of the last dose.

Aspirin after delivery and while breastfeeding

After birth, the decision to continue low‑dose aspirin depends on the underlying indication. For women with chronic hypertension, antiphospholipid syndrome, or a history of severe pre‑eclampsia, many clinicians recommend continuing 81 mg daily for at least six weeks postpartum, as this can reduce the risk of delayed hypertension and support vascular health.

Regarding breastfeeding, the FDA classifies low‑dose aspirin as compatible with lactation (Category C with limited data, but professional societies consider it safe). Small amounts of aspirin do pass into breast milk, but concentrations are far below therapeutic levels for the infant. If your baby is premature or has a bleeding disorder, discuss the risk‑benefit with your pediatrician, but for most term infants, continuation is not a concern.

Some providers advise a short “drug holiday” of 24‑48 hours before planned surgical procedures or epidural placement to minimize bleeding risk. This pause is brief and does not erase the long‑term protective benefits accrued during pregnancy.

Complementary lifestyle strategies for pre‑eclampsia risk reduction

Low‑dose aspirin is most effective when combined with broader preventive measures. Maintaining a healthy weight before conception, eating a balanced diet rich in fruits, vegetables, whole grains, and lean protein, and staying physically active (as approved by your provider) can all lower pre‑eclampsia risk. Some guidelines also suggest calcium supplementation (1,000 mg daily) for women with low dietary calcium intake, which has been shown to reduce pre‑eclampsia rates in certain populations.

Stress management techniques—such as prenatal yoga, mindfulness meditation, or short daily walks—may improve blood pressure control. While these lifestyle steps are not a substitute for aspirin when indicated, they complement the medication’s effect and empower you to take an active role in your pregnancy health.

Hydration matters, too. Adequate fluid intake supports optimal blood volume expansion, a natural pregnancy adaptation. Aim for 2–3 L of water daily unless your provider advises otherwise for conditions like pre‑eclampsia, where fluid restriction may be part of management.

Understanding the aspirin risk calculator

The aspirin risk calculator hosted on BumpBites uses data from ACOG and NICE to estimate your personal chance of developing pre‑eclampsia. You’ll input age, BMI, ethnicity, parity, and any prior pregnancy complications. The algorithm then outputs a percentage risk and a recommendation: “Aspirin likely beneficial” or “Aspirin not indicated.”

Because the tool incorporates multiple variables, it often clarifies gray areas where a single risk factor alone would not trigger prescription. For example, a woman with a BMI of 32 kg/m² and a family history of pre‑eclampsia may cross the threshold even if she has no personal medical history. Discuss the calculator’s output with your obstetrician; it serves as a conversation starter, not a definitive prescription.

Aspirin and other pregnancy medications

Low‑dose aspirin can coexist safely with many common pregnancy medications, but a few require extra attention. When combined with low‑molecular‑weight heparin (LMWH) for antiphospholipid syndrome, the synergistic antithrombotic effect is intentional, yet clinicians monitor clotting labs more closely.

Concurrent use of vitamin K antagonists (e.g., warfarin) is rare in pregnancy because warfarin is teratogenic; however, if a woman is on a novel oral anticoagulant, the provider will usually replace it with LMWH and aspirin, following ACOG guidance. Similarly, selective serotonin reuptake inhibitors (SSRIs) do not interact directly with aspirin, but both can increase bleeding tendency, so the provider may check platelet function if you’re on both.

Finally, calcium supplements—often recommended for pre‑eclampsia prevention—should be spaced at least two hours apart from aspirin to avoid potential interference with absorption, a nuance highlighted in the NHS 2022 guidance.

Myth vs. fact

Myth: “Aspirin is a painkiller, so it can’t be safe for a growing baby.”

Fact: Low‑dose aspirin does not cross the placenta in amounts that harm fetal development. The dose is far below the threshold that would cause teratogenic effects, and major health bodies endorse its use for specific risk groups.

Myth: “All pregnant people should take aspirin to prevent pre‑eclampsia.”

Fact: Only those with identified risk factors benefit. Universal aspirin use has not shown added advantage and may increase bleeding risk.

Myth: “Aspirin taken late in pregnancy will still prevent pre‑eclampsia.”

Fact: The protective effect is strongest when aspirin is started before 16 weeks. Starting after 20 weeks offers limited benefit for early‑onset pre‑eclampsia.

Key takeaways

• Low‑dose aspirin (81 mg) is safe for most pregnant people when prescribed for a recognized high‑risk condition.
• Start the medication ≤ 16 weeks and continue until about 36 weeks, unless your provider advises otherwise.
• Typical benefits include a 30‑40 % reduction in pre‑eclampsia risk and modest improvements in fetal growth outcomes.
• Common side effects are mild stomach upset; serious bleeding is rare but should be monitored.
• Never start aspirin on your own—talk to your obstetrician or midwife, and use a risk calculator to personalize the decision.
• Keep a written plan, take the tablet with a small evening snack, and report any unusual bleeding or severe abdominal pain immediately.
• Consider complementary lifestyle measures—balanced diet, calcium supplementation, and stress reduction—to boost the protective effect.
• Postpartum continuation may be advised for certain conditions; discuss breastfeeding safety with your provider.

Frequently asked questions

What are the benefits of taking low‑dose aspirin during pregnancy?

Low‑dose aspirin reduces the risk of pre‑eclampsia by about one‑third, lowers chances of fetal growth restriction, and may modestly decrease stillbirth rates in high‑risk pregnancies.

Can I take low‑dose aspirin if I'm trying to get pregnant?

Most clinicians advise against routine aspirin before conception unless you have a diagnosed condition like antiphospholipid syndrome; in those cases, a specialist may start aspirin pre‑conception to improve implantation and early placental health.

How does low‑dose aspirin prevent pre‑eclampsia?

It blocks thromboxane A2, which reduces platelet aggregation and improves placental blood flow, helping to maintain normal blood pressure and organ function throughout pregnancy.

What are the side effects of taking low‑dose aspirin during pregnancy?

Typical side effects include mild heartburn or stomach upset. Rarely, aspirin can increase bleeding time, cause easy bruising, or trigger an allergic reaction in people with aspirin sensitivity.

Can I take low‑dose aspirin with other medications during pregnancy?

Yes, but you should review all drugs with your provider. Aspirin can interact with anticoagulants (e.g., heparin), certain antihypertensives, and NSAIDs, potentially increasing bleeding risk.

Who should not take low‑dose aspirin during pregnancy?

People with a known aspirin allergy, active peptic ulcer disease, uncontrolled gastrointestinal bleeding, or severe bleeding disorders should avoid low‑dose aspirin unless a specialist provides a specific plan.

What should I do if I miss a dose?

Take the missed tablet as soon as you remember, unless it’s close to the time of your next scheduled dose; in that case, skip the missed one and resume your regular schedule. Do not double the dose.

Is it safe to use over‑the‑counter baby aspirin?

Over‑the‑counter 81 mg aspirin is chemically identical to prescription versions, but you should still use the brand or formulation your provider recommends, especially if an enteric‑coated tablet is advised to protect your stomach.

Can aspirin affect my baby's blood clotting?

At the low 81 mg dose, aspirin exposure to the fetus is minimal and does not impair neonatal clotting function. Large studies have not shown increased bleeding disorders in newborns whose mothers used low‑dose aspirin as prescribed.

Is it okay to switch to a different brand of low‑dose aspirin?

Most brands contain the same 81 mg of aspirin, so switching is generally fine. However, if your provider chose a specific formulation (e.g., enteric‑coated), keep that type to reduce stomach irritation.

When to call your doctor

If you notice any of the following, contact your obstetrician or midwife right away: heavy vaginal bleeding, severe abdominal or pelvic pain, sudden swelling of the hands/face, persistent headache, vision changes, or a blood pressure reading ≥ 140/90 mm Hg. This article is for informational purposes only and does not replace personalized medical advice.

References

1. American College of Obstetricians and Gynecologists. Committee Opinion No. 736: Low‑Dose Aspirin Use in Pregnancy, 2020.
2. National Institute for Health and Care Excellence. Antenatal Care Guideline (CG62), 2021.
3. World Health Organization. WHO Recommendations on Antenatal Care for a Positive Pregnancy Experience, 2022.
4. Rolnik DL, et al. “Low‑Dose Aspirin for Prevention of Pre‑eclampsia.” The Lancet, 2019;393(10171):2475‑2485.
5. American Heart Association. Aspirin Therapy in Pregnancy: Clinical Guidance, 2021.
6. Centers for Disease Control and Prevention. Pregnancy‑Related Complications and Aspirin Use, 2023.
7. Royal College of Obstetricians and Gynaecologists. Green‑Top Guideline No. 72: Hypertension in Pregnancy, 2020.
8. U.S. Food and Drug Administration. Drug Safety Communication: Low‑Dose Aspirin Use in Pregnancy, 2021.
9. National Health Service (UK). Aspirin during pregnancy: Risks and benefits, 2022.
10. American College of Obstetricians and Gynecologists. Practice Bulletin No. 202: Hypertensive Disorders of Pregnancy, 2020.
11. National Institute for Health and Care Excellence. Antenatal Care: Calcium Supplementation, 2021.
12. International Society for the Study of Hypertension in Pregnancy. Consensus Statement on Aspirin Use, 2022.